[Advances and perspectives in heart/lung transplantation].
Thoracic organ transplantation has evolved as standard therapy in end-stage cardiac and pulmonary failure. Meanwhile more than 50.000 heart, 2500 heart-lung and 10.000 lung transplantations have been performed worldwide. Improvements in patient selection as well as in the postoperative management have led to 1-year survival rates of 70-90%. Long-term results are still influenced by the development of graft vessels disease, bronchiolitis obliterans syndrome and malignancies. Furthermore, indications and results of different procecures will be presented and new developments discussed.
Klinik für Thorax-, Herz und Gefäßchirurgie, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, D-30623 Hannover, E-mail: harringer@thg.mh-hannover.de, Germany.
W
W
Harringer
Klinik für Thorax-, Herz und Gefäßchirurgie, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, D-30623 Hannover, E-mail: harringer@thg.mh-hannover.de, Germany.
A
A
Haverich
Key words Transplantation – heart –, lung – immunosuppression – graft vessel disease – bronchiolitis obliterans syndrome